Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off. Plus: Stop Hiding Your Wins

Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, ...

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Is Recursion Pharmaceuticals a Meme Stock?

Is that the case? Let's look into it and decide whether the company is worth investing in.
BBC

Prime numbers, factors and multiples

WATCH: What is a factor? A factor is a number that divides into another number exactly, without leaving a remainder. Find out in this KS3 Bitesize maths guide. WATCH: How to find factors using ...
Hosted on MSN

Netflix and Amazon Prime are using AI algorithms that hide content from some users, media executive says

Artificial intelligence may be changing how content is made, but its bigger impact on media is how the technology is altering who is able to access that content, one media executive said. Jyoti ...
UNHCR

Republic of Türkiye

Are you a refugee, asylum-seeker or stateless person looking for help? Visit the HELP site to find support and services from UNHCR. Since 1960, UNHCR has worked in close partnership with the Republic ...